Cagrilintide × NextGen Peptides - Lab Test, December 2025
Test results
About this test
Cagrilintide 13.65mg from NextGen Peptides achieves 99.923% purity according to this independent HPLC analysis with UV detection coupled to mass spectrometry. The test was conducted by Freedom Diagnostics Testing on December 18, 2025.
Cagrilintide is a GLP-1 receptor agonist researched for weight management and metabolic regulation. A purity level of 99.923% demonstrates pharmaceutical-grade synthesis with minimal contamination and high product consistency.
The certificate of analysis (COA #2512160117) is available for download and includes chromatographic data and mass spectrometry confirmation. The sample appears as a white lyophilized powder.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.